Tuttle Ventures Scores Early Win
Actionable Market Insights from Darin Tuttle | Vision | Courage | Patience
Yesterday, Biogen Inc., ticker symbol BIIB, gained 38% in 1 DAY on news of FDA approval of a new drug to fight Alzheimer’s.
At Tuttle Ventures, we could not BE MORE EXCITED. We took notice of this company back in April, before any of the headlines had a clue.
When you look for great companies at fair prices, you choose to focus on SUBSTANCE over STYLE.
Our high conviction wasn’t based solely on the approval of the new experimental drug but also the R&D culture in neurology, wide operating margins, and potential growth opportunities in biosimilar businesses.
We continue to believe that Biogen Inc., is a future healthcare leader in an innovative field.
This demonstrates Tuttle Ventures investment philosophy:
Vision | Courage | Patience
If you didn’t see the latest Yahoo! Finance news article check it out here.
Tuttle Ventures, LLC